Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17249688 | 0.90 | ALDH1A1 (0.39) | CYP3A4CYP2C9CYP2C19POLBALDH1A1 | |
| SCHEMBL16761024 | 0.86 | CYP3A4 (0.41) | CYP3A4CYP2C9CYP2C19POLBALDH1A1 | |
| SCHEMBL16761022 | 0.83 | ALDH1A1 (0.42) | CYP3A4CYP2C9CYP2C19POLBALDH1A1 | |
| SCHEMBL13469072 | 0.82 | ACHE (0.38) | CYP3A4CYP2C9CYP2C19POLBALDH1A1 | |
| SCHEMBL16761019 | 0.82 | TSHR (0.37) | CYP3A4CYP2C9CYP2C19POLBTSHR | |
| SCHEMBL16979607 | 0.81 | CYP3A4 (0.38) | CYP3A4CYP2C9CYP2C19POLBALDH1A1 | |
| SCHEMBL2992966 | 0.81 | CYP3A4 (0.40) | CYP3A4CYP2C9CYP2C19POLBTSHR | |
| SCHEMBL2646513 | 0.81 | POLB (0.43) | CYP3A4CYP2C9CYP2C19POLBTSHR | |
| SCHEMBL10987006 | 0.80 | ALDH1A1 (0.34) | CYP3A4CYP2C9CYP2C19POLBALDH1A1 | |
| SCHEMBL16978355 | 0.80 | CYP3A4 (0.34) | CYP3A4CYP2C9CYP2C19POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 815 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264651-A1 | ELECTROLYTE AND LITHIUM ION BATTERIES MADE THEREWITH | WILDCAT DISCOVERY TECHNOLOGIES, INC. (US) | 2025-12-26 | — | — | WO | claimed |
| US-20180198166-A1 | NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME | UBE INDUSTRIES, LTD. (JP) | 2018-07-12 | — | — | US | claimed |
| EP-2882030-B1 | NON-AQUEOUS ELECTROLYTE AND ENERGY STORAGE DEVICE USING THE SAME | UBE INDUSTRIES (JP) | 2017-06-21 | — | — | EP | claimed |
| US-20150221985-A1 | NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME | UBE INDUSTRIES, LTD. (JP) | 2015-08-06 | — | — | US | claimed |
| EP-2882030-A1 | NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE USING SAME | Ube Industries, Ltd. (JP) | 2015-06-10 | — | — | EP | claimed |
| US-8795884-B2 | Nonaqueous secondary battery and electronic device | HITACHI MAXELL, LTD. (JP) | 2014-08-05 | — | — | US | claimed |
| US-8574757-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-11-05 | — | — | US | claimed |
| US-20120264011-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-10-18 | — | — | US | claimed |
| US-20110052980-A1 | NONAQUEOUS SECONDARY BATTERY AND ELECTRONIC DEVICE | MAXELL, LTD. (JP) | 2011-03-03 | — | — | US | claimed |
| EP-1409512-A1 | 20-FLUORO-17(20)-VINYL STEROIDS AS INHIBITORS OF C17-20-LYASE AND 5-ALPHA REDUCTASE | Aventis Pharma S.A. (FR) | 2004-04-21 | — | — | EP | claimed |
| EP-0946492-B1 | NOVEL 2-FLUOROACRYLIC ACID DERIVATIVES, NOVEL MIXTURES OF HERBICIDES AND ANTIDOTES AND THE USE THEREOF | BAYER CROPSCIENCE GMBH (DE) | 2003-06-18 | — | — | EP | claimed |
| US-6413951-B2 | ENZYME INHIBITOR | AVENTIS PHARMACEUTICALS, INC. | 2002-07-02 | — | — | US | claimed |
| US-20020019548-A1 | 20-Fluoro-17(20)-vinyl steroids | AVENTIS PHARMA S.A. (FR) | 2002-02-14 | — | — | US | claimed |
| WO-2002000681-A1 | 20-FLUORO-17(20)-VINYL STEROIDS AS INHIBITORS OF C17-20-LYASE AND 5-ALPHA REDUCTASE | AVENTIS PHARMA S.A. (FR) | 2002-01-03 | — | — | WO | claimed |
| US-5972839-A | MIXTURE WITH PLANT SAFENING AGENT | HOECHST SCHERING AGREVO GMBH (DE) | 1999-10-26 | — | — | US | claimed |
| EP-4743465-A1 | BICYCLIC MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-20260132109-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2026-05-14 | — | — | US | disclosed |
| US-4171318-A | 9-(SUBSTITUTED PHENYL), 4 OR 6-FLUORO-RETINOIC ACID DERIVATIVES, ANTITUMOR AND ANTIACNE AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1979-10-16 | — | — | US | disclosed |
| US-4169100-A | FLUORO AND TRIFLUOROMETHYL SUBSTITUTED 9-(4-ALKOXY-2,3,6-TRIALKYLPHENYL)-2,4,6,8-NONATETRAENOIC ACIDS, ESTERS AND AMIDES, ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1979-09-25 | — | — | US | disclosed |
| US-4137246-A | ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1979-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132109-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | STING1, IRF3, CGAS | CYP3A4 4593/4885CYP2C9 4756/4885CYP2C19 4843/4885 |
| US-20020019548-A1 | 20-Fluoro-17(20)-vinyl steroids | CYP17A1, HSD17B11, HSD3B1 | CYP3A4 167/4885CYP2C9 158/4885CYP2C19 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.